SEC Form 4 · accession 0001179110-15-007775
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John K Clarke
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 3:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2015 | M | 38,400 | $10.44 | A | 107,523 | D | |
| Common Stock | May 12, 2015 | S | 38,400 | $19.96 | D | 69,123 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $10.44 | May 12, 2015 | M | 38,400 | D | May 26, 2009 | May 26, 2015 | Common Stock | 38,400 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $19.88 to $20.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.